The role of human papillomavirus in nongenital cancers (Q38069126)

28 August 2017

1 reference

title

The role of human papillomavirus in nongenital cancers (English)

1 reference

28 August 2017

Dan P Zandberg

1

1 reference

28 August 2017

Ranjana Bhargava

series ordinal

2

1 reference

28 August 2017

Simon Badin

series ordinal

3

1 reference

28 August 2017

Kevin J Cullen

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

19 December 2012

1 reference

28 August 2017

1 reference

28 August 2017

volume

63

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

57-81

1 reference

Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The epidemiology of human papillomavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Papillomaviruses in the causation of human cancers - a brief historical account

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus testing in the prevention of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Cervical cancer: from Hippocrates through Rigoni-Stern to zur Hausen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Noncondylomatous wart virus infection of the postmenopausal cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus infection: epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The viral etiology of AIDS-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Different modes of human papillomavirus DNA replication during maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Changing patterns of tonsillar squamous cell carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Cancers with increasing incidence trends in the United States: 1999 through 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Sexual behavior in the United States: results from a national probability sample of men and women ages 14-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Changes in sexual behaviours: from secular trends to public health policies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus in oral exfoliated cells and risk of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Prevalence of oral HPV infection in the United States, 2009-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Oral sexual behaviors associated with prevalent oral human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Six-month natural history of oral versus cervical human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Two-Week versus Six-Month Sampling Interval in a Short-Term Natural History Study of Oral HPV Infection in an HIV-Positive Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus-related head and neck tumors: clinical and research implication

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Prevalence of high-risk human papillomavirus types (HPV-16, HPV-18) and their physical status in primary laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

HPV-associated head and neck cancer: a virus-related cancer epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus and survival of patients with oropharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Transoral robotic surgery and human papillomavirus status: Oncologic results

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

African-American and white head and neck carcinoma patients in a university medical center setting. Are treatments provided and are outcomes similar or disparate?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus-active head and neck cancer and ethnic health disparities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Oropharyngeal cancer, race, and the human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Clinical implications of human papillomavirus in head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Radiosensitization of oropharyngeal squamous cell carcinoma cells by human papillomavirus 16 oncoprotein E6∗I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

High-risk human papillomavirus in oral squamous cell carcinoma of young patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Clinical and molecular prognostic factors in operable laryngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Promoter methylation in head and neck tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Sexual practices, sexually transmitted diseases, and the incidence of anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Sexually transmitted infection as a cause of anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

School wellness policies: effects of using standard templates

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Malignancies that occur before and after anal cancer: clues to their etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Association of Cancer With AIDS-Related Immunosuppression in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus infection and anal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Anal and cervical intraepithelial neoplasia: possible parallel

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Aetiological parallel between anal cancer and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Trends in incidence of anal cancer in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Patterns of anal carcinoma by gender and marital status in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Changing patterns of anal cancer incidence in the United States, 1940-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Anal cancers among HIV-infected persons: HAART is not slowing rising incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Aetiology, pathogenesis, and pathology of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Molecular biology of squamous cell carcinoma of the anus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Clinical presentation and natural course of anogenital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Understanding the burden of human papillomavirus-associated anal cancers in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Environmental causes of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

HPV infections and oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: Result from a cross-sectional study in a high-risk region of China

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Lung cancer in never smokers: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Lung cancer in never smokers--a different disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Lung cancer incidence in never smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Assessment of human papillomavirus in lung tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Incidence of human papilloma virus in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus-16 presence and physical status in lung carcinomas from Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

Carcinogenicity of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21167

21 January 2018

Identifiers

DOI

10.3322/CAAC.21167

1 reference

28 August 2017

1 reference